Most cosmetic wrinkle serums make claims they can't back up. Pola's Wrinkle Shot Medical Serum is one of the few that can. The product launched in 2017 as Japan's first quasi-drug approved for cosmetic wrinkle-improvement claims — a regulatory category Pola effectively created through its NEI-L1 peptide development program. The Japanese quasi-drug framework requires substantial clinical efficacy data to approve a wrinkle-improvement claim; Pola spent over a decade developing the underlying active and demonstrating measurable wrinkle reduction in regulatory clinical trials before launching the product. That history is the differentiator and the justification for the luxury pricing.
The NEI-L1 peptide is the core of the formulation. Listed on INCI as sodium formylhippurate trifluoroacetylisobutyl dipeptide-42 amide, the molecule was specifically designed by Pola's research division to modulate neutrophil elastase activity in the dermis. Neutrophil elastase is an enzyme released during chronic inflammatory processes that degrades dermal elastin — one of the key proteins maintaining skin firmness. As elastin breaks down (aided by UV exposure and chronic low-grade inflammation), skin loses elasticity and wrinkles form. NEI-L1 reduces the elastase activity, preserving more of the existing elastin structure. The published Pola clinical data supporting the quasi-drug approval shows measurable wrinkle reduction at 12-16 weeks of consistent twice-daily application, with peak effects at 24 weeks.
The rest of the formulation is engineered to support the active delivery. Dimethicone leads the INCI as the primary silicone vehicle, with petrolatum at second position providing the substantial occlusive layer that holds the NEI-L1 in extended skin contact. Cyclopentasiloxane (volatile silicone for spreading), trimethylsiloxysilicate (film-forming silicone), and dimethicone/vinyl dimethicone crosspolymer (texture-building silicone elastomer) round out the silicone phase. The combination creates a substantial barrier-occlusive layer at the targeted application points — important for the wrinkle-improvement mechanism that needs sustained dwell time to operate.
The immediate optical effects come from hydroxyapatite (calcium phosphate mineral that fills surface texture irregularities) and mica (light-reflecting mineral). Both contribute to visible fine-line smoothing within minutes of application — this is optical surface filling rather than biological action, but it's a real effect that complements the slower clinical mechanism. The immediate optical results help users perceive product effectiveness while the cumulative biological effect builds.
The supporting bioactives include royal jelly (Pola's signature B.A-line ingredient providing brand-identity continuity), arnica and chamomile (botanical anti-inflammatories), peach leaf and thyme extracts (additional anti-inflammatory and antioxidant character), and tocopherol (vitamin E antioxidant for formula stability and modest topical benefit). Squalane and caprylic/capric triglyceride provide skin-mimetic emollient cushioning. Zinc oxide adds minor UV-protective character.
In practical use the serum is a targeted-application treatment. Apply a pea-sized amount to specific wrinkle areas — expression lines, crow's feet, between the brows, lip lines, nasolabial folds — after toner and before moisturizer in both AM and PM routines. The thick translucent serum spreads with smooth silicone slip and absorbs in about 90 seconds with a slightly powdery matte finish from the minerals. The immediate optical smoothing is visible; the biological wrinkle reduction emerges over weeks.
The fragrance is recognizable mature Pola floral — fragrance-reactive skin should rule this out. Royal jelly inclusion is a contact-allergen consideration for users with bee-product sensitivities. The silicone-and-petrolatum base may not appeal to ingredient purists who prefer botanical formulations.
Value is the genuine consideration. At $130 for 20g at Japanese pricing, the per-gram cost is among the highest in the cosmetic wrinkle serum category — about $6.50 per gram. The 20g tube lasts 4-5 months at targeted-application twice-daily use, putting monthly cost at $26-33. International markup pushes this to $160-200 at non-Japanese retailers. Compared to prescription tretinoin (under $20 per 20g at most pharmacies), the Wrinkle Shot is dramatically more expensive — but it offers cosmetic-tier convenience without the retinoid irritation, plus the regulatory clinical backing. Compared to luxury Western wrinkle serums (Augustinus Bader The Cream, La Mer Genaissance, SkinCeuticals AGE Interrupter), the Wrinkle Shot is competitively priced for the regulatory clinical depth.
Who this is for: anyone 35+ with visible expression lines or crow's feet looking for a clinically-validated cosmetic wrinkle treatment without the retinoid irritation; Pola line users completing their aging-care routine with the regulatory-backed treatment step; users who specifically value the Japanese quasi-drug regulatory framework as meaningful clinical validation; anyone who has tried Western wrinkle products without satisfaction and wants to try a different mechanism.
Who should skip: budget-conscious shoppers for whom prescription tretinoin delivers comparable (or stronger) wrinkle improvement at a fraction of the cost; chronically sensitive skin (fragrance and royal jelly flags); cruelty-free or vegan purchasers (royal jelly disqualifies vegan; Pola's China distribution disqualifies cruelty-free); users seeking a full-face wrinkle treatment rather than targeted application.
The broader take: this is one of the few cosmetic wrinkle serums that earned its claims rather than just marketing them. The NEI-L1 mechanism is genuinely different from retinoid-pathway products and has the regulatory clinical backing to support the wrinkle-improvement claim. The price is steep but reflects real research investment and ongoing clinical efficacy validation. For users in the target profile who value the regulatory differentiation, the Wrinkle Shot earns its place at the top of the Japanese luxury wrinkle category.
